These changes reversed glioma-associated immunosuppression by reducing regulatory T cell (Treg) recruitment and suppressing immunosuppressive cytokines, including interleukin-10 (IL-10) and transforming growth factor-β (TGF-β), which are upregulated in TMZ-resistant gliomas. The gene discussed is IL10; the disease is glioma.